from Today's $tockhead.
PYC Therapeutics (ASXYC)
PYC also received an Orphan Drug Designation (ODD) from the US FDA in late May for its drug candidate, PYC-001, aimed at treating OPA1-associated vision loss.
PYC-001 is said to be a significant advancement in precision therapy. The drug was designed to restore the expression of the OPA1 gene to levels necessary for optimal retinal function.
Utilising the company’s proprietary drug-delivery technology, PYC has tackled a major hurdle for RNA drugs by ensuring effective delivery to the targeted cells affected by ADOA (Autosomal Dominant Optic Atrophy).
ADOA is a progressive and irreversible blinding eye disease. It affects approximately 1 in every 35,000 people representing a market size of ~$2 billion per annum.
ADOA is caused by a mutation in one copy of the OPA1 gene, which results in inadequate levels of OPA1 gene expression, impacting the normal function of retinal ganglion cells.
- Forums
- ASX - By Stock
- PYC - General Discussion
from Today's $tockhead. PYC Therapeutics (ASX:PYC) PYC also...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $559.9M |
Open | High | Low | Value | Volume |
12.5¢ | 12.5¢ | 12.0¢ | $185.3K | 1.515M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 166662 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 39575 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 166662 | 0.120 |
9 | 834833 | 0.115 |
11 | 941370 | 0.110 |
17 | 1373823 | 0.105 |
25 | 1451907 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 25000 | 2 |
0.130 | 130000 | 2 |
0.135 | 468000 | 3 |
0.140 | 1524545 | 4 |
0.145 | 756800 | 3 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online